Description: 
Anti-Complement C5 Reference Antibody (ravulizumab)(CHA747) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Product type: 
Antibody
Host: 
CHO
Target name: 
Complement C5
Target species: 
Human
Isotype: 
IgG
Buffer: 
100 mM Pro-Ac 20 mM Arg pH5.0
Applications: 
ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay
More info: 
Email: info@sobekbio.com
Orders: 
Email: orders@sobekbio.com